Results 191 to 200 of about 462,629 (365)

Autosomal dominant polycystic kidney disease. [PDF]

, 1993
John C. Lieske, F. Gary Toback
openalex   +1 more source

Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies?

Pharmacology Research &Perspectives, Volume 13, Issue 4, August 2025.
ABSTRACT Chloride channels are involved in many cellular processes, including cell volume regulation, modulation of cell excitability, and electrolyte and water secretion. Mutations of these proteins are associated with heterogeneous diseases such as myotonia, cystic fibrosis, epilepsy, deafness, lysosomal storage disease, and various kinds of renal ...
Paola Laghetti, Ilaria Saltarella, Simone Dell'Atti, Jean‐François Desaphy, Concetta Altamura   +4 more
wiley   +1 more source

Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History

Kidney International Reports
Introduction: Recently, the monoallelic loss-of-function IFT140 variant was identified as a causative gene for autosomal dominant polycystic kidney disease (ADPKD).
Takuya Fujimaru, Takayasu Mori, Akinari Sekine, Motoko Chiga, Shintaro Mandai, Hiroaki Kikuchi, Yutaro Mori, Yu Hara, Tamami Fujiki, Fumiaki Ando, Koichiro Susa, Soichiro Iimori, Shotaro Naito, Ryoichi Hanazawa, Akihiro Hirakawa, Toshio Mochizuki, Tatsuya Suwabe, Yoshifumi Ubara, Shinichi Uchida, Eisei Sohara   +19 more
doaj  

Adult polycystic kidney disease: Studies of the defect in urine concentration

, 1972
Manuel Martínez–Maldonado, Jackson Joe Yium, Garabed Eknoyan, Wadi N. Suki   +3 more
openalex   +1 more source

Two step procedure for early diagnosis of polycystic kidney disease with polymorphic DNA markers on both sides of the gene. [PDF]

, 1990
M.H. Breuning, F.G.M. Snijdewint, Johannes G. Dauwerse, Jasper J. Saris, Egbert Bakker, P. Pearson, Gjb Vanommen   +6 more
openalex   +1 more source

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease

Diabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4311-4319, August 2025.
Abstract Aims To evaluate whether type 2 diabetes status modifies the efficacy and safety of combining zibotentan (zibo), a selective endothelin receptor antagonist, and dapagliflozin (dapa) compared to placebo plus dapagliflozin in individuals with chronic kidney disease (CKD).
Victor Wasehuus, J. David Smeijer, Phil Ambery, Peter J. Greasley, Emma Wijkmark, David C. Wheeler, Peter Rossing, Hiddo J. L. Heerspink   +7 more
wiley   +1 more source

Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1. [PDF]

, 1990
Sushil Kumar, William J. Kimberling, Patricia A. Gabow, Yin Yao Shugart, Sandra Pieke-Dahl   +4 more
openalex   +1 more source

Focal Spot, Spring 2001 [PDF]

, 2001
https://digitalcommons.wustl.edu/focal_spot_archives/1087/thumbnail ...

core   +1 more source

Diffusion Tensor Imaging (DTI) as a Non‐Invasive Tool for Assessing Pediatric Kidney Transplants: A Feasibility Study

Pediatric Transplantation, Volume 29, Issue 5, August 2025.
Our study demonstrates the feasibility of using diffusion tensor imaging (DTI) to evaluate pediatric kidney transplants. Significant differences in fractional anisotropy (FA) and track length were observed between transplanted and healthy kidneys, reflecting altered microstructural organization.
Suraj D. Serai, Tatiana Morales, Daniel Vossough, Sandra Amaral, Hansel J. Otero, Bernarda Viteri Baquerizo   +5 more
wiley   +1 more source

Polycystic Disease of the Kidneys [PDF]

Postgraduate Medical Journal, 1953
openaire   +3 more sources